We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN β IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -1.25 | 4.8 | 4.9899 | 4.41 | 62942 | 4.70291064 | CS |
4 | -0.52 | -9.88593155894 | 5.26 | 6.2899 | 4.41 | 70329 | 5.1844457 | CS |
12 | -1.14 | -19.387755102 | 5.88 | 6.2899 | 3.85 | 86069 | 4.74153811 | CS |
26 | 0.09 | 1.93548387097 | 4.65 | 6.96 | 3.8181 | 107580 | 5.27676365 | CS |
52 | -5.86 | -55.2830188679 | 10.6 | 10.764 | 3.8181 | 413078 | 7.28452801 | CS |
156 | -49.86 | -91.3186813187 | 54.6 | 102.6 | 3.8181 | 536152 | 29.10068001 | CS |
260 | -186.26 | -97.5183246073 | 191 | 356.4 | 3.8181 | 462683 | 53.92127281 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions